Gordon Gund was born in 1939 in Cleveland, Ohio. He was educated at Groton School in Massachusetts and later graduated from Harvard University. Gund served as an officer in the U.S. Navy in the Western Pacific from 1961-65. Mr. Gund's interest in working in wood, clay and bronze began more than 25 years ago. He was exposed to art at an early age, attending art classes at the Cleveland Museum of Art with his siblings. He studied watercolor while in college, and became an avid photographe. while in the Navyr. Gund's interest in sculpture began when a friend introduced him to wood carving - his first carvings were of shorebirds, fish and seals. Working with professional sculptors, Gund continued to expand his sculptural capabilities, making clay sculptures and readying them for plaster and bronze castings. A six-foot version of one of his earlier bronze works Flukes is on permanent display at the Grounds for Sculpture in Hamilton, NJ and another casting is on display at the Anne d'Harnoncourt Sculpture Garden of the Philadelphia Museum of Art. "While with my eyes I can't see the shapes I create, I feel them over and over again with my hands and my mind, and the result is in my mind forever. It takes me more time and patience than most with sight and letting go is generally felt with more uncertainty. So, it is extremely satisfying to finish something that I have doubted along the way, woken up with in the middle of the night, spent a lot of time on and given a lot of love. It is especially satisfying and enjoyable when others I care about truly like the result when it is finally done." Mr. Gund is predominantly known for his successful endeavors as a businessman, investor and prominent philanthropist. He is the Chairman and CEO of Gund Investment Corporation in Princeton, NJ and is also the former majority owner of the Cleveland Cavaliers NBA team. In 1970, Gund lost his sight from retinitis pigmentosa (RP) and in 1971, along with his wife and others; he co-founded the Foundation Fighting Blindness (FFB) to help find treatments and cures for RP and allied retinal degenerative diseases.